FDA Authorizes 23andMe to Report Results of Direct-to-Consumer Pharmacogenetics Test to Customers without a Prescription, Bypassing Doctors and Clinical Laboratories
Event Information
Qiagen EGFR Assay Approved in Japan as CDx to Pfizer NSCLC Drug
NEW YORK (GenomeWeb) – Qiagen said Wednesday that its Therascreen EGFR RGQ PCR kit has been approved by the Japanese Pharmaceuticals and Medical Device Agency as a companion diagnostic with Pfizer’s Vizimpro (dacomitinib) for EGFR mutation-positive, inoperable, or recurrent non-small cell lung cancer.
Connect With Us
Connect with us on the CDx Forum Group site on LinkedIn – https://www.linkedin.com/groups/12063094/